Tag: ICH

Edoxaban—an oral anticoagulant medication—failed to reduce stroke or systemic embolism but did increase major bleeding in high-risk patients with atrial fibrillation (AF) who had...

People with atrial fibrillation (AF) who have a stroke could benefit from receiving blood-thinning treatments—known as direct oral anticoagulants (DOACs)—at an earlier stage than...